Evidence map›Paper›PMID 33224945›Full record

ReviewFrontiers in cell and developmental biology2020

Post-translational Modifications of IκBα: The State of the Art.

Xiuli Wang, Hanlin Peng, Yaqian Huang, Wei Kong, Qinghua Cui, Junbao Du, Hongfang Jin

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Metabotropic signaling downstream of GABANPJ Parkinson's disease · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in immunology · 2026
    Article
  8. Article
  9. Frontiers in immunology · 2026
    Article
  10. Mouse Trophoblast Stem Cells Are Deficient in TNFα-Activated NFκB Signaling Pathway and Inflammatory Response.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xiuli WangDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Hanlin PengDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Yaqian HuangDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Wei KongDepartment of Physiology and Pathophysiology, Peking University Health Science Center, Beijing, China.
Qinghua CuiDepartment of Biomedical Informatics, Centre for Noncoding RNA Medicine, School of Basic Medical Sciences, Peking University, Beijing, China.
Junbao DuDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Hongfang JinDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Peking University · CNPeking University First Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nuclear factor-kappa B (NF-κB) signaling pathway regulates a variety of biological functions in the body, and its abnormal activation contributes to the pathogenesis of many diseases, such as cardiovascular and respiratory diseases and cancers. Therefore, to ensure physiological homeostasis of body systems, this pathway is strictly regulated by IκBα transcription, IκBα synthesis, and the IκBα-dependent nuclear transport of NF-κB. Particularly, the post-translational modifications of IκBα including phosphorylation, ubiquitination, SUMOylation, glutathionylation and hydroxylation are crucial in the abovementioned regulatory process. Because of the importance of the NF-κB pathway in maintaining body homeostasis, understanding the post-translational modifications of IκBα can not only provide deeper insights into the regulation of NF-κB pathway but also contribute to the development of new drug targets and biomarkers for the diseases.

Indexed as

IκBαNF-κBphosphorylationpost-translational modificationsSUMOylationubiquitination

Identifiers

PMID33224945
PMCPMC7674170
OpenAlexW3095588579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.